Warning letter
Meta Labs Pharmaceuticals, LLC: warning letter of May 15, 2026
FDA warning letter 725130 · Human Foods Program
Key facts
| Reference number | 725130 |
|---|---|
| Company | Meta Labs Pharmaceuticals, LLC |
| Subject | Dietary Supplement/New Drug/Misbranded |
| Issue date | May 15, 2026 |
| Posted date | Jun 2, 2026 |
| Issuing office | Human Foods Program |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.210(h)(5), 111, 111.70(b), 111.70(e), 111.75(a), 111.75(a)(1)(i), 111.75(a)(1)(ii), 111.75(a)(2)(ii), 111.75(c), 111.205(b)(1), 111.210, 111.210(d) and 13 more |
| Inspection city | Roswell |
| Inspection ZIP | 30076 |
| Inspection start date | Dec 8, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: